Notice of Preliminary Results

RNS Number : 4632R
Advanced Medical Solutions Grp PLC
09 March 2016
 

09 March 2016

Advanced Medical Solutions Group plc

 

("AMS" or the "Group")

Notice of Preliminary Results

 

Winsford, UK: 9 March 2016 - Advanced Medical Solutions Group plc (AIM: AMS.L), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, will announce its unaudited preliminary results for the year ended 31 December 2015 on Wednesday 16 March 2016.

 

A briefing for analysts will be held at 9.30am on the day of the results. Please contact Consilium Strategic Communications for further details.

 

- Ends -

 

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc

+44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Mary Tavener, Group Finance Director


Consilium Strategic Communications

+44 (0) 20 3709 5700

AMS@consilium-comms.com

Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys


Investec Bank plc (NOMAD & Broker)

 +44 (0) 20 7597 5970

Gary Clarence / Daniel Adams / Patrick Robb


 

About Advanced Medical Solutions Group plc - see www.admedsol.com 

 

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.

 

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in 65 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Group has approximately 470 employees.  For more information please see www.admedsol.com.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOREAXDPEAFKEFF
UK 100

Latest directors dealings